Selecting the right technology for pain assessment is critical to study success. This new guide helps clinical teams evaluate eCOA platforms through practical frameworks that balance scientific requirements with site and patient experience. Download today: hubs.ly/Q03k5s1b0

What does the FDA’s recent AI guidance mean for the future of clinical trials? The draft guidance lays the groundwork for smarter, faster drug development, focusing on safety and transparency. More in our blog by YPrime founder Shawn Blackburn: hubs.ly/Q03k-SqX0 #AI #FDA

If your clinical tech isn’t easy to use, it’s a barrier—not a solution. Discover why sponsors rely on YPrime’s industry-leading eCOA platform to keep trials on track: hubs.ly/Q03lgkR_0 #ClinicalTrials #ClinicalTech #eCOA #HealthTech #ClinicalResearch

Protocol amendments are inevitable. Delays don’t have to be. 76% of trials require amendments—and too often they take 6+ weeks to implement. YPrime’s IRT platform is built to adapt fast, enabling changes 4x faster than traditional systems. Learn more: hubs.ly/Q03lZd6f0

When a sponsor needed to add a new country (India) late in a global study, the typical 9-week localization timeline threatened critical delays. With YPrime’s AI-powered Migration Tool, part of our eCOA platform, we delivered a smarter, faster solution: hubs.ly/Q03mJmKj0 #AI

OCT East Coast is finally here! Join us tomorrow and Wednesday at booth 58 and see firsthand how our eCOA, IRT, and eConsent can help you improve your clinical research. Schedule a demo here: hubs.ly/Q03m-sVz0 #OCTEast #OCTEast2025 #ClinicalTrials #ClinicalResearch

At YPrime, purpose powers progress. On Clinical Trials Day, we celebrate the people behind every trial, innovation, and outcome—driven by a belief in better. #ClinicalTrialsDay #ClinicalResearch #ClinicalTrials

Clinical trials can’t afford delays. Manual data change workflows waste time and increase the risk of errors. That's where YPrime’s eCOA Automated DCF comes into play. Learn more here: hubs.ly/Q03ppPBf0 #eCOA #DCF #Automation #DataQuality #PatientCentric #ClinicalResearch

Will you be at OCT UK & Ireland next week? We're excited to meet you there! Stop by booth 25 to chat about all things eCOA, IRT, and eConsent. Schedule a demo today: hubs.ly/Q03qhrRP0 #OCTUK #OCTIreland #ClinicalTech #ClinicalResearch #ClinicalTrials

Clinical trial complexity is rising, and so is the need for real-time, high-quality data. Our latest playbook breaks down how sponsors and CROs are integrating connected devices (like glucometers and CGMs) directly into eCOA platforms. Access our playbook: hubs.ly/Q03rdbBL0

In studies involving children, unpredictability is challenging. Learn how we helped maintain global consistency and drive patient engagement in a pediatric migraine study with our eCOA platform—ultimately reducing dropout rates and accelerating timelines: hubs.ly/Q03sw4qr0

The new ICH E6(R3) guidelines raise the bar for Good Clinical Practice—and for supporting technologies. As trials grow more complex, your IRT system must do more than IRT solutions of the past. Learn how YPrime IRT is leading the change: hubs.ly/Q03t9kP60 #IRT #ICH #GCP

CGM or BGM? It depends on your trial. Join us for a one-of-a-kind conversation on July 30 to explore what really impacts GLP-1 study success. Register today: hubs.ly/Q03v3lXw0 #eCOA #GLP1 #BGM #CGM #ClinicalTech #ClinicalResearch #ClinicalTrials

Are you losing deals because of eCOA implementation delays? Top sponsors are choosing CROs who can deliver quality data faster. Is your eCOA keeping pace? Get the playbook that turns eCOA into your competitive advantage: hubs.ly/Q03vtqLD0 #CROStrategy #eCOA #ClinicalTrials

Joint assessments are essential in inflammatory arthritis trials, but paper-based methods slow teams down and increase error risk. YPrime’s eCOA streamlines assessments, improves consistency, and reduces site burden. Learn about our TSJC assessment here: hubs.ly/Q03xJH6j0

ICH E6(R3) takes effect in the EU today. This means new expectations for vendor oversight, system traceability, and risk-based management—especially for IRT. At YPrime, our IRT is built for E6(R3). Learn what the changes mean: hubs.ly/Q03y6JK-0 #E6R3 #ClinicalTrials #IRT

Show us your audit trail. If these words evoke stress, then let's talk. Leading sponsors are building this capability now—not scrambling during inspections. Let our team help you with a platform that alleviates audit stress. Schedule your eCOA or IRT demo: hubs.ly/Q03zcSfD0

GLP-1 trials are accelerating, and so is the complexity. In his latest blog, YPrime's Karl McEvoy shares how eCOA innovation can help sponsors manage large-scale, multi-endpoint studies with greater efficiency: hubs.ly/Q03Bq2mZ0 #GLP1 #ClinicalTrials #eCOA #DigitalHealth

Pain studies require advanced eCOA to support episodic symptoms, psychological impacts, and more—with patient-first technology. Discover how the right eCOA makes the difference in our new playbook: hubs.ly/Q03CrqM80 #eCOA #PainManagement #ClinicalTrials #ClinicalResearch

We’re proud to share that YPrime's Ryan Ridge has been named a finalist for Informa's IRT Young Professional Award. This recognition celebrates rising leaders who are shaping the future of clinical trial operations—and Ryan is doing just that. Vote today: hubs.ly/Q03CKYXw0